Savara Inc (SVRA) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Savara Inc   (NASDAQ: SVRA)


Savara Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Savara Inc 's ROA in the second quarter of 2026?
Savara Inc recorded a cumulative net loss of $-139 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -68.91%.

However, within the Healthcare sector 657 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4092, from total ROA ranking in the first quarter of 2026 at 4737.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 17.65 % 17.08 % 19.05 % -38.08 % 26.04 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -139 -129 -119 -116 -110
Return On Assets (TTM) -68.91 % -66.42 % -63.6 % -65.44 % -55.61 %
SVRA's Total Ranking # 4092 # 4737 # 4174 # 4128 # 4187
Total Assets (TTM) in million 193 222 253 141 164
Seq. Total Assets Change -13.07 % -12.54 % 79.84 % -13.95 % -13.5 %
Seq. Net Income Change - - - - -

SVRA's 5 Years Annual ROA >> Back to SVRA Management Effectiveness >> Compare SVRA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 299
Sector # 658
Overall # 4077

Return On Assets Statistics
High Average Low
95.48 %
-30.57 %
-68.95 %
(Dec 31 2013)   (Jun 30 2026)



  News about Savara Inc Return on Assets ROA

Savara Announces New Employment Inducement Grant

Savara Inc.: A New Wave of Innovation and GrowthIn the constantly evolving field of biopharmaceuticals, Savara Inc. stands out as a dynamic player. Based in Langhorne, Pennsylvania, and listed on Nasdaq under the ticker symbol SVRA, Savara has made a series of strategic maneuvers that have piqued the interest of investors, medical professionals, and industry observers alike. New Employment Inducement GrantOn September 5, 2024, Savara’s Board of Directors Compensation Committee greenlit inducement awards for a new recruit. This grant includes options to purchase 20,000 shares of the company’s common stock and restricted stock units (RSUs). This move is an essential instrument in attracting top-tier talent, a crucial component for any company poised for innovation. By offering stock options and RSUs, Savara aligns the new employee’s interests with the longer-term prosperity and performance of the company.



Financial Statements
Savara Inc 's Assets $ 193 million SVRA's Balance sheet
Savara Inc 's Income $ -40 million Quarterly SVRA's Income Statement
SVRA's Income by Division See SVRA's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 19.05 % 26.55 % 29.39 % -26.38 % 80.67 %
Total Assets in million 253 213 168 130 177
Y / Y Net Income Change - - - - -
Net Income in million -119 -96 -55 -38 -43
Annual Return On Assets -46.89 % -45.04 % -32.52 % -29.35 % -24.36 %

SVRA's 5 Years Annual ROA >> Back to SVRA Management Effectiveness >> Compare SVRA ROA to its Competitors



More Return On Assets Ratios
SVRA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SVRA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SVRA's Competitors
Subscribers only: Roa for Savara Inc 's Suppliers
Subscribers only: Return On Assets for SVRA's Customers

You may also want to know
SVRA's Roi SVRA's Inventory Turnover Ratio SVRA's Growth Rates SVRA's Dividend Comparisons
SVRA's Profitability Ratios SVRA's Asset Turnover Ratio SVRA's Dividend Growth
SVRA's Roe SVRA's Valuation Ratios SVRA's Financial Strength Ratios SVRA's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-08T22:28:39+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.